Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

LOGSX vs. PRHSX: which is better?

Bottom line

LOGSX vs PRHSX: the short answer

LOGSX (Live Oak Health Sciences Fund) and PRHSX (T. Rowe Price Health Sciences Fund, Inc.) are both mutual funds.

But PRHSX is far broader, holding 279 positions to 28 for LOGSX, so beyond the top names it adds exposure LOGSX doesn't have.

PRHSX is cheaper at 0.83% vs 1.04% — a difference of $21 a year per $10,000 invested.

Over five years, LOGSX returned +8.1% a year vs +4.2% for PRHSX.

Updated Nov 19, 2026

LOGSX vs PRHSX side by side

LOGSXPRHSX
TypeMutual fundMutual fund
Fund familyOak AssociatesT. Rowe Price
CategoryHealth Care SectorHealth Care Sector
Expense ratio1.04%0.83%
Annual cost per $10k$104$83
10-yr cost on $10k (prospectus)$1,271$1,025
Max front load——
12b-1 fee——
1-yr return+19.6%+17.7%
5-yr return (annualized)+8.1%+4.2%
10-yr return (annualized)+7.3%+9.1%
Best quarter+13.4%+23.5%
Worst quarter−13.1%−15.8%
Net assets (fund)$56.1M$11.9B
Number of holdings28279
Portfolio turnover24%62%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearLOGSXPRHSXDifference
2025+19.6%+17.7%+1.9%
2024+0.2%+1.8%−1.7%
2023+1.2%+3.1%−1.9%
2022+3.7%−12.2%+15.9%
2021+17.5%+13.3%+4.2%
2020+6.0%+30.1%−24.1%
2019+19.0%+29.1%−10.1%
2018−4.0%+1.2%−5.2%
2017+13.4%+28.0%−14.5%
2016−0.4%−10.4%+10.0%

Source: Fund prospectus bar charts

Holdings overlap

9 of LOGSX's top 25 holdings also appear in PRHSX's top 25.

Shared top holdings
HoldingLOGSXPRHSX
Cardinal Health Inc5.86%1.03%
Amgen Inc4.86%1.82%
Bristol-myers Squibb Company4.02%2.11%
Johnson & Johnson3.77%6.63%
Gilead Sciences Inc3.50%2.82%
Vertex Pharmaceuticals Inc3.26%2.28%
Merck & Company Inc3.16%4.01%
Intuitive Surgical Inc2.99%1.87%
Eli Lilly & Company1.99%14.28%

Source: SEC Form N-PORT

LOGSX top 10

  1. N/a — 6.91%
  2. Cardinal Health Inc — 5.86%
  3. Jazz Pharmaceuticals Plc — 5.77%
  4. United Therapeutics Corp — 5.11%
  5. Exelixis Inc — 4.95%
  6. Amgen Inc — 4.86%
  7. Lantheus Holdings Inc — 4.68%
  8. Novartis Ag — 4.67%
  9. Mckesson Corp — 4.53%
  10. Cencora Inc — 4.46%

PRHSX top 10

  1. Eli Lilly & Co — 14.28%
  2. Johnson & Johnson — 6.63%
  3. Unitedhealth Group Inc — 5.99%
  4. Abbvie Inc — 5.10%
  5. Merck & Co. Inc. — 4.01%
  6. Gilead Sciences Inc — 2.82%
  7. Thermo Fisher Scientific Inc — 2.52%
  8. Vertex Pharmaceuticals Inc — 2.28%
  9. Bristol-myers Squibb Co — 2.11%
  10. Abbott Laboratories — 1.89%

FAQ

What is the difference between LOGSX and PRHSX?
LOGSX (Live Oak Health Sciences Fund) and PRHSX (T. Rowe Price Health Sciences Fund, Inc.) are both mutual funds. But PRHSX is far broader, holding 279 positions to 28 for LOGSX, so beyond the top names it adds exposure LOGSX doesn't have.
Which is cheaper, LOGSX or PRHSX?
PRHSX has the lower expense ratio (0.83%).
Should I own both LOGSX and PRHSX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.